Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21037/acs.2017.03.05 http://scihub22266oqcxt.onion/10.21037/acs.2017.03.05 C5387154!5387154!28446996     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Cardiothorac+Surg 2017 ; 6 (2): 75-87 Nephropedia Template TP {{tp|p=28446996|t=2017. Barrett?s esophagus: best practices for treatment and post-treatment surveillance |pdf=|usr=}}{{28446996}} gab.com Text Barrett s esophagus: best practices for treatment and post-treatment surveillance JO: Ann Cardiothorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=28446996 #FOAvip Barrett?s esophagus (BE) is a premalignant condition that increases the risk of esophageal adenocarcinoma (EAC). Significantly more common in the Western world, risk factors include increased age, male sex, white race, gastro-esophageal reflux disease (GERD), central obesity, and cigarette smoking. The rates of progression to cancer depend on the grade of Barrett?s dysplasia. Screening for BE is recommended in patients with GERD and additional risk factors. Endoscopic surveillance of patients with BE likely improves overall outcomes. Advanced endoscopic imaging can help increase the efficiency of current endoscopic surveillance. Endoscopic therapy is safe and effective for the treatment of dysplastic BE and intramucosal EAC, but ongoing surveillance following treatment is necessary. This review will cover screening, surveillance, advanced imaging, chemoprevention, endoscopic treatment, and post-treatment surveillance of BE. Twit Text FOAVip Barrett s esophagus: best practices for treatment and post-treatment surveillance ????Ann Cardiothorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=28446996 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28446996 #FOAvip English Wikipedia <ref>{{Cite pmid|28446996}}</ref> Barrett?s esophagus: best practices for treatment and post-treatment surveillance #MMPMID28446996 Mansour NM; El-Serag HB; Anandasabapathy S Ann Cardiothorac Surg 2017[Mar]; 6 (2): 75-87 PMID28446996show ga Barrett?s esophagus (BE) is a premalignant condition that increases the risk of esophageal adenocarcinoma (EAC). Significantly more common in the Western world, risk factors include increased age, male sex, white race, gastro-esophageal reflux disease (GERD), central obesity, and cigarette smoking. The rates of progression to cancer depend on the grade of Barrett?s dysplasia. Screening for BE is recommended in patients with GERD and additional risk factors. Endoscopic surveillance of patients with BE likely improves overall outcomes. Advanced endoscopic imaging can help increase the efficiency of current endoscopic surveillance. Endoscopic therapy is safe and effective for the treatment of dysplastic BE and intramucosal EAC, but ongoing surveillance following treatment is necessary. This review will cover screening, surveillance, advanced imaging, chemoprevention, endoscopic treatment, and post-treatment surveillance of BE. äBarrett?s esophagus: best practices for treatment and post-treatment s(epmc).pdf DeepDyve Pubget Overpricing